Emergent BioSolutions moves closer to facility approval for anthrax vaccine
June 21, 2016 at 10:30 AM EDT
Emergent BioSolutions cleared a hurdle toward receiving FDA approval for a large-scale facility for making BioThrax, a vaccine for pre-exposure protection against anthrax.